Systemic sclerosis (SSc) is a rare chronic disease that involves internal organs and often leads to intestinal, kidney, heart, and lung problems like interstitial lung disease (ILD), which is one of the leading causes of death for these patients. That’s why diagnosing and treating SSc-ILD early is so critical, and this program is designed to help you do just that by identifying risk factors, clinical features, current and emerging therapies, and strategies for taking a multidisciplinary approach to SSc-ILD.